SCHEMBL513742

SCHEMBL513742

C1=COC(c2cccnc2)=CO1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
CYP2A6 P11509 6/20 0.50
CYP3A4 P08684 3/20 0.50
CYP1A2 P05177 2/20 0.50
CHRNB2 P17787 2/20 0.47
CHRNA5 P30532 2/20 0.47
CHRNA4 P43681 2/20 0.47
SMN1; SMN2 Q16637 6/20 0.45
TP53 P04637 5/20 0.45
MAPT P10636 3/20 0.44
HSD17B10 Q99714 3/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
LMNA P02545 1/20 0.44
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44
PPARA Q07869 3/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4439161 0.76 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL9983004 0.71 CYP2A6 (0.47) ALDH1A1CYP2A6CYP3A4CYP1A2CHRNB2
SCHEMBL29419014 0.70 CYP2A6 (1.00) ALDH1A1CYP2A6CYP3A4CYP1A2SMN1; SMN2
SCHEMBL30473120 0.70 CYP2A6 (1.00) ALDH1A1CYP2A6CYP3A4CYP1A2SMN1; SMN2
SCHEMBL120088 0.70 CYP2A6 (1.00) ALDH1A1CYP2A6CYP3A4CYP1A2SMN1; SMN2
Benzene SCHEMBL27934930 0.67 CYP2A6 (0.94) ALDH1A1CYP2A6CYP3A4CYP1A2SMN1; SMN2
Hydrochloric Acid SCHEMBL4831090 0.67 CYP2A6 (0.94) ALDH1A1CYP2A6CYP3A4CYP1A2SMN1; SMN2
SCHEMBL28247322 0.67 CYP2A6 (0.94) ALDH1A1CYP2A6CYP3A4CYP1A2SMN1; SMN2
SCHEMBL28301145 0.67 CYP2A6 (0.94) ALDH1A1CYP2A6CYP3A4CYP1A2SMN1; SMN2
SCHEMBL27812368 0.67 CYP2A6 (0.94) ALDH1A1CYP2A6CYP3A4CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372973-B2 Prokineticin 1 receptor antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2013-02-12 US disclosed
US-20120028997-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS COATS STEVEN J (US) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028997-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS PROKR1, PROKR2, GIPR ALDH1A1 3674/4885CYP2A6 3896/4885CYP3A4 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.